Mylan And Biocon Introduce Fulphila In Australia
Pegfilgrastim Biosimilar Is Partnership’s Third Australian Launch
Mylan and Biocon have launched their Fulphila biosimilar version of pegfilgrastim in Australia, marking the pair’s third local biosimilar launch under their partnership.
